Japan's epigenetics market is evolving rapidly, with a strong emphasis on AI-driven research and personalized medicine, addressing complex diseases t ...

Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. East Asian Americans are ...

Takeda Pharmaceuticals has named Julie Kim as the first woman to lead the 244-year-old Japanese drugmaker, a rarity in senior management in the world’s fourth-largest economy. Kim, a US citizen ...

Tokyo, Jan. 30 (Jiji Press)--Japan's Takeda Pharmaceutical Co. said Thursday that its president and CEO, Christophe Weber, will step down at its general shareholders meeting in June 2026.

Innovative national contractor joins BioMed Realty and Takeda to build a state-of-the-art lab and office space in Kendall Square, a hub of global innovation and epicenter of Cambridge’s ...

Takeda has leased the property's approximately 600,000-square-foot of lab and office space, creating a purpose-built research and development facility to deliver life-transforming therapies for ...

(Photo: Business Wire) Innovative national contractor joins BioMed Realty and Takeda to build a state-of-the-art lab and office space in Kendall Square, a hub of global innovation and epicenter of ...

Julie Kim is set to replace Christophe Weber as the new chief executive officer of Takeda Pharmaceutical Co., becoming the first woman to lead the more than 240-year-old Japanese drugmaker.